← Back

Level Zero Health πŸ‡ΊπŸ‡Έ Hiring Β· 9 open roles β†—

Pre-seed

Wearable using DNA-based sensors and nanotechnology for real-time hormone monitoring via interstitial fluid.

About Level Zero Health

The company offers a wearable device that utilizes advanced DNA-based sensors and nanotechnology for real-time hormone monitoring, providing high-quality data correlated with blood readings through interstitial fluid. This minimally invasive solution enables continuous monitoring of hormonal changes, allowing for immediate adjustments in treatment while requiring minimal user action.

Level Zero Health is a US-based company founded in 2023, now around 23 people. It has raised $12.5M in disclosed funding. FundFinder classes it as Health & Bio.

Founded by Irene Jia (Co-founder and CTO; repeat founder; previously Ada Zanditon, International arts collective; Imperial College London), Ula Rustamova (Co-founder and CEO; repeat founder; previously Centre for the Study of Terrorism and Political Violence, CombiniCo; Baku State University).

Its investors also appear on FundFinder's most-active lists for Pre-seed Β· Healthcare & Wellbeing (52 funds), Pre-seed Β· DeepTech (51 funds), Pre-seed Β· Climate & Sustainability (50 funds).

Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.

Want the latest on Level Zero Health? Our research agent pulls the current description, latest round and full investor base from public sources (about a minute).

Hiring now Β· 9 live roles, checked daily

Showing the newest 8 Β· all 9 on their careers page β†—

Pre-seed Β· Jul 2026

  • Exceptional Ventures β€” Exceptional Ventures Fund 1 will be a Β£20M/$24M vehicle mainly focused on the UK and Europe, with some investments made further afield, focusing on early-stage startups, primarily at pre-seed and seed stage.
  • Unruly Capital β€” Unruly backs founders building at the frontiers of what's possible today. Β· cheques Β£250k – Β£500k
Raising your own round? See which European funds fit β†’